Testing drugs for hepatitis C called daclatasvir and sofosbuvir showed that they help in the treatment of coronavirus. It is reported BAGNET with reference to a study by Brazilian research Association name of Oswaldo Cruz (Fiocruz).
It is noted that the use of antivirals at an early stage can improve the clinical picture of patients and to reduce the number of severe cases.
According to experts, the daclatasvir and sofoluwe managed to prevent the propagation of infection in the three types of cells, including the cells of the lungs. Scientists also said that protective in infected cells the production of substances that cause inflammation, slows down.
In the study, daclatasvir showed higher efficiency compared with sofosbuvir, said the experts. In addition, both drugs showed better results in contrast to the antiviral drug broad spectrum of action of ribavirin and antiretroviral atazanavir.